Item 8.01. Other Events. On June 1, 2026, Teleflex Incorporated (the “Company”) announced that it priced its private offering of $500.0 million aggregate principal amount of its 5.875% Senior Notes due 2032 (the “Notes”). The Company intends to use the net proceeds from the offering, together with cash on hand, to redeem all of its outstanding 4.625% Senior Notes due 2027 (the “2027 Notes”).…
Filed Jun 2, 2026Accepted Jun 1, 2026, 6:35 PM EDTCIK 96943Accession 0001193125-26-251951
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. Teleflex is the home of Arrow®, Barrigel®, Deknatel®, LMA®, Pilling®, QuikClot®, Rusch®, UroLift®, and Weck® - trusted brands united by a common sense of purpose.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 8.01Item 8.01 - Other Events
Item 8.01. Other Events.
On June 1, 2026, Teleflex Incorporated (the “Company”) announced that it priced its private offering of $500.0 million aggregate principal amount of its 5.875% Senior Notes due 2032 (the “Notes”). The Company intends to use the net proceeds from the offering, together with cash on hand, to redeem all of its outstanding 4.625% Senior Notes due 2027 (the “2027 Notes”). A copy of the press release announcing the pricing of the offering is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The offering is expected to close on or about June 15, 2026, subject to customary closing conditions.
The offering of the Notes will be made in a private transaction in reliance upon an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), in the United States only to investors who are reasonably believed to be “qualified institutional buyers,” as that term is defined in Rule 144A under the Securities Act, or to certain non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act. The Notes and the related guarantees have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States without registration or an applicable exemption from registration requirements.
This announcement shall not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall there be any sale of the Notes, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This Current Report on Form 8-K is not an offer to purchase or a solicitation of an offer to purchase, nor does it constitute a notice of redemption with respect to, the 2027 Notes.
Filed exhibits (1)
EX-99.1 (by filename) d71849dex991.htm
EX-99.1
2
d71849dex991.htm
EX-99.1
EX-99.1
Exhibit 99.1
Contact: Lawrence Keusch
Vice President, Investor Relations and Strategy Development
610-948-2836
FOR IMMEDIATE RELEASE
TELEFLEX INCORPORATED ANNOUNCES PRICING OF $500 MILLION SENIOR NOTES OFFERING
WAYNE, Pa. - June 1, 2026 - Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it priced its private
offering of $500.0 million aggregate principal amount of 5.875% senior notes due 2032 (the “Notes”) at an issue price of 100.000%. The sale of the Notes is expected to close on June 15, 2026, subject to customary closing
conditions.
The Notes will be guaranteed by each of Teleflex’s existing and future wholly-owned domestic subsidiaries that is a guarantor or other
obligor under its credit agreement and certain other indebtedness.
Teleflex intends to use the net proceeds from the offering, together with cash on
hand, to redeem all of its outstanding 4.625% Senior Notes due 2027 (the “2027 Notes”).
The offering of the Notes will be made in a private
transaction in reliance upon an exemption from the registration requirements of the Securities Act of 1933, as amended (…